Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Scientech AGM Information 2025

May 27, 2025

52347_rns_2025-05-27_9a52d3ad-f265-48ec-b156-e469ca6701db.pdf

AGM Information

Open in viewer

Opens in your device viewer

SCIENTECH CORPORATION 2025 ANNUAL SHAREHOLDERS’ MEETING MIMUTES

Type of Meeting: Physical shareholders’ meeting

Time and Date: May 23, 2025 at 9 a.m

Place: 6nd Floor, No. 182, Bade Road, Hsinchu City

Total outstanding SCIENETECH shares (excluding shares with no voting right as provided by Article 179 of the Company Law) ： 80,328,000 shares

Total shares represented by shareholders present in person or by proxy ： 44,353,108 shares Percentage of shares held by shareholders present in person or by proxy ： 55.21%

Directors present ： HUNG-LIANG HSIEH(Convenor of the Sustainability Committee), Independent director CHENG-LI YANG (audit committee convener and the member of the remuneration committee), Independent director Shui-Chuan, Shin (the member of the audit committee and the remuneration committee and the Sustainability Committee), Independent director Chun-Chi, Lin (the member of the audit committee and the remuneration committee convener and the member of the Sustainability Committee ) , MING-CHI HSU(the member of the Sustainability Committee), WEI-LIN HSIEH; Total six directors is present

Attendees person：HUI-MIN HUANG (CPA), Michelle H. Chu, Shao-Che Chuang (Associate vice president, Accounting Division), Chi Wu (Manager of the Audit Office)

Chairman：HUNG-LIANG HSIEH Secretary： Shu-Chen, Shen

The aggregate shareholding of the shareholders present by person or by proxy constituted a quorum. The chairman called the meeting to order.

One. Chairman’s Address (omitted)

Two. Reports

Proposal 1 ： 2024 Business Report (see attachment I)

Proposal 2 ： Audit Committee Review Report for 2024 (see attachment II)

Proposal 3 ： The convener of the Audit Committee reports on the communication between

himself/herself, members of the independent directors, and the chief internal auditor.

Description:

The Company’s Audit Committee is composed entirely of independent directors. Every month the chief internal audit officer submits the audit report of the previous period to the independent directors. If the directors have comments on the report or need more information, the chief internal audit officer will immediately offer assistance or provide relevant information to the

1

independent directors for their understanding. The Company convenes an Audit Committee meeting at least quarterly, during which the chief internal audit officer reports to the independent directors about the implementation of the internal audit operation and the relevant internal control problems spotted therefrom; the independent directors may raise questions to gain insights into the problems and have a good grasp of the problems with the internal control system, and may instruct that the audit content be strengthened; a special meeting may be called at any time in case of any material anomaly.

Proposal 4 ： Remuneration for employees and directors of 2024.

Description:

The Company’s employee remuneration and director remuneration for 2024 stood at 108,700 thousand and 14,000 thousand, respectively, constituting 8.67% and 1.12%, respectively, of the profit before tax of 2024 in the amount of $1,254,093 (excluding directors’ remuneration and employee remuneration), which complies with the Company’s Articles of Incorporation.

Description:

  • (I) According to Article 20 of the Company’s Articles of Incorporation, the Board of Directors has the power to draft an earnings distribution proposal, and may decide on the distribution proportion of cash dividends through a resolution, which shall then be reported to the Shareholders' Meeting.

  • (II) From among the earnings of 2024, the Board of Directors distributed shareholder dividends in the amount of 361,476,000 dollars in cash, that is 4.5 dollars for each share held. Dividends distributed were rounded to the nearest integral; fractional dividends less than 1 dollar were aggregated and recognized as the Company’s other income

  • (III) This proposal was passed by the Board of Directors through a resolution. If subsequently the dividend payout ratio is changed because the number of the Company’s outstanding shares is changed due to the Company’s buying back treasure shares or retiring expired treasury shares, or due to any other reason, it is proposed that the Shareholders’ Meeting authorize the Chairman of the Board to adjust the shareholder dividend ratio based on the total dividend amount indicated in the Earnings Distribution Proposal approved this time.

  • Proposal 6 ： Report on implementation of issuance of the first domestic unsecured

  • convertible corporate bond and the second domestic unsecured convertible corporate bond.

2

Name of the
Bond		 First domestic unsecured
convertible corporate bond		 Second domestic unsecured
convertible corporate bond
Issuance date 2024/6/7 2024/6/19
Issuance amount NT$200,000,000.- NT$1,000,000,000.-
Face value NT$100,000.- NT$100,000
Issuanceprice NT$100.- NT$117.07.-
Issuance period 3 years
(Expirydate: 2027/06/07)		 3 years
(Expirydate: 2027/06/19)
Coupon rate 0% 0%
Principal
payment method		 Except under the circumstances
when the holder of this
Convertible Corporate Bond
holder converts the bond into the
Company's common shares by
Article 10 of the Regulations or
exercises the put right in
accordance with Article 19 of the
Regulations, or the Company
redeems the bond in advance in
accordance with Article 18 of the
Regulations, or when the
Company repurchases and cancels
the bond through TPEx, the
Company shall repay the principal
amount of these bonds in cash in a
single lumpsum upon maturity		 Except under the circumstances
when the holder of this Convertible
Corporate Bond holder converts the
bond into the Company's common
shares by Article 10 of the
Regulations or exercises the put
right in accordance with Article 19
of the Regulations, or the Company
redeems the bond in advance in
accordance with Article 18 of the
Regulations, or when the Company
repurchases and cancels the bond
through TPEx, the Company shall
repay the principal amount of these
bonds in cash in a single lump sum
upon maturity
The state of
conversion of
the corporate
bonds as of the
conversions
suspension date
(2025/3/25)		 As of the conversion suspension
date, 0 convertible bonds were
converted, yielding 0 converted
shares, and the face value of the
remaining unconverted bonds is
NT$200,000,000.。		 As of the conversion suspension
date, 0 convertible bonds were
converted, yielding 0 converted
shares, and the face value of the
remaining unconverted bonds is
NT$1,000,000,000元 。

Three.Acceptance

Proposal 1 (Proposed by the Board of Directors)

Subject Matter: The Company’s 2024 Business Report and Financial Statements (including the Consolidated Financial Statements), proposed for acceptance.

Description:

The Company’s Business Report of 2024 has been reported in Proposal 1 in the Reports session, and is submitted to the Shareholders' Meeting for acceptance. The Company’s 2024 Financial Statements and Consolidated Financial Statements were all be audited by CPA Hui-Min Huang and CPA Yu-Cheng Hsin from Deloitte & Touche Taiwan. (see attachment III ).

Voting Results:Shares represented at the time of voting 44,353,108

Voting Results % of the total represented sharepresent
Votes in favor:43,313,297 votes 97.65%

3

Voting Results % of the total represented sharepresent
Votes against：10,249 votes 0.02%
Votes invalid：0 votes 0%
Votes abstained：1,029,562 votes 2.32%

RESOLVED, that the 2024 Business Report and Financial Statements were hereby accepted as submitted.

Proposal 2 (Proposed by the Board of Directors)

Subject Matter: The Company’s Earnings Distribution Proposal, submitted for acceptance.

Description: Below is the Company’s Earnings Distribution Proposal presented in the form of tables.

Unit: New Taiwan dollar

Item
Amount		 Description
Unappropriated earnings - beginningofperiod $ 1,714,393,123 4.5 dollars of cash
dividends for each
share
Effect of retrospective application and
retrospective restatement
0
Reconciled unappropriated earnings - beginning of
period
1,714,393,123
Defined benefits plan remeasurement recognized
in retained earnings
340,433
Reconciled unappropriated earnings 1,714,733,556
Netprofits for theperiod
926,982,841
Legal reserveprovision(10%)
(92,732,327)
Special reserveprovision
0
Distributable earnings of thisperiod 2,548,984,070
Distribution item: shareholder dividends
(361,476,000)
Unappropriated earnings - end ofperiod 2,187,508,070
Note:
(1) The Company's paid-in capital is 803,280,000 dollars which is divided into 80,328,000 issued
shares, leaving the number of outstanding shares at 80,328,000 shares.
(2) If subsequently the dividend payout ratio is changed because the number of the Company’s
outstanding shares is changed due to the Company’s buying back treasure shares or retiring
expired treasury shares, or due to any other reason, it is proposed that the Board of Directors
authorize the Chairman of the Board to adjust the shareholder dividend ratio based on the
total dividend amount indicated in the Earnings Distribution Proposal approved this time.
(3) Source of the earnings distributed: NT$ 361,476,000 dollars of the Company’s profit after tax
of 2024.

Chairman of the Board: HUNG-LIANG HSIEH

Manager: Accounting Manager: MING-CHI HSU SHAO-CHE CHUANG

4

Chairman of the Board: HUNG-LIANG HSIEH

Voting Results:Shares represented at the time of voting 44,353,108

Voting Results % of the total represented sharepresent
Votes in favor:43,329,333 votes 97.69%
Votes against：16,254 votes 0.02%
Votes invalid：0 votes 0%
Votes abstained：1,007,521 votes 2.27%

RESOLVED, that the above proposal was hereby approved as proposed

Four. Discussions :

Proposal 1 (Proposed by the Board of Directors)

Subject Matter: Proposal on the amendment to the Articles of Incorporation;

proposed for discussion

Description: In response to the Presidential promulgation on August 7, 2024 (Hua-Zong-Yi-YiZi No. 11300069631), amending Article 14, Paragraph 6 of the Securities and Exchange Act, the Company hereby revises its "Articles of Incorporation" and submits the attached comparison table of the amended "Articles of Incorporation." Please refer to Attachment 4 of this handbook.

Voting Results:Shares represented at the time of voting 44,353,108

Voting Results % of the total represented sharepresent
Votes in favor:43,334,755 votes 97.70%
Votes against：11,266 votes 0.02%
Votes invalid：0 votes 0%
Votes abstained：1,007,087 votes 2.27%

RESOLVED, that the above proposal was hereby approved as proposed

Five. Extempore Motion:

There being no other business and special motion, upon a motion duly made and seconded, the meeting was adjourned.

There is no questions from shareholders at this shareholders’ meeting.

5

Chapter 3. Attachments

I. 2024 Business Report Dear Scientech Shareholders:

2024 operating results:

In 2024, the Company has seen a consolidated operating revenue of NT$9,688,280 thousand, an increase of NT$2,776,299 thousand from last year; operating profit of NT$1,115,549 thousand , an increase of NT$397,827 thousand from last year; an income before tax of NT$1,276,704 thousand, an increase of NT$416,360 thousand from last year; a net income of NT$926,983 thousand (net of the income tax of NT$349,721 thousand), an increase of NT$276,681 thousand from last year; and an EPS of NT$11.54 dollars.

Item 2023 2024 Amount
increased or
decreased		 Growth rate
Operatingrevenue 6,911,981 9,688,280 2,776,299 40%
Operating grossprofit 2,201,332 2,905,827 704,495 32%
Operating profit 717,722 1,115,549 397,827 55%
Netprofit before tax 860,344 1,276,704 416,360 48%
Netprofit after tax 650,302 926,983 276,681 43%
Earnings per share (NT$)
(after taxes)		 8.10 11.54 3.44 42%

  • II. Outline of the 2025 Business Plan:

  • (I) Business policy and important production and marketing policies

  • Having mastered the key R&D technologies requisite for independently making semiconductor wet process equipment (both single-wafer processing and batch-wafer processing), the Company has demonstrated considerable competitive advantages at both the front-end and the back-end of semiconductor Advanced Packaging process. After all the years of R&D, all models of the Temporary Bonding/Debonding System (TBDB) series have all been successfully developed and put to business use; such models have become an important revenue source for the Company. Going forward this year, we will continue to enhance our R&D strength and production capacity and develop new applications, so as to meet customer needs and thus create long-term favorable development conditions for our Equipment Manufacturing business.

  • In terms of wafer reclaim, to satisfy the customers’ needs for the advanced semiconductor process, the Company has been actively engaged in developing new process and improving existing process. On the 300mm wafer reclaim front, the Company will move forward to attain more advanced process capability to meet customers’ needs this year.

  • 3.Upholding the R&D spirit as always, the Company actively develops

  • semiconductor/FPD/LED machinery and more advanced wafer processing technologies while competing for new products for our agent business; in 2025, the Company will diversify operating risks and generate revenues and profits from more diversified sources.

(II) Expected sales and its bases

6

Revenue is expected to grow in 2025, judging from current market conditions, prospects of development for the semiconductor/compound semiconductor/FPD/OLED industries, and the scaled-up operations with respect to Equipment Manufacturing.

III. Future development strategies

To catch up with industrial development, the Company will strive to boost the agent business in different fields while grasping the development of technologies requisite for equipment manufacturing, and improving wafer reclaim process technology and production capacity.

  • IV. Impact of external competition, regulatory environment, and macroeconomic environment

The semiconductor industry scales up due to demands from the various industries such as human-machine interface, digital media, artificial intelligence, and the Internet of Things. With clients successively launching their 10/7/5/3 nm advanced process, capital expenditure on semiconductor equipment will be driven up, which is a favorable factor for the Company’s development.

Once again, we would like to say thank you to all shareholders, directors, clients, and suppliers for their offering long-term support and encouragement to the Company. In a new year going forward, we will uphold the idea of sustainable operations and keep improving ourselves so that we meet your expectations for Scientech.

We wish you all good health and good luck!

Chairman of the Board: Manager: HUNG-LIANG HSIEH MING-CHI HSU

Accounting Manager: SHAO-CHE CHUANG

7

II. Audit Committee Review Report for 2024

SCIENTECH CORPORATION

Audit Committee Review Report

After reviewing the 2024 Business Report, Earnings Distribution Proposal, Individual and Consolidated Financial Statements (including the balance sheet, statement of comprehensive income, statement of changes in equity, and statement of cash flows) that were prepared by the Company’s Board of Directors, the Audit Committee did not find any non-conformities, and thus prepared this report in accordance with Article 14-4 of the Securities and Exchange Act and Article 219 of the Company Act.

Very Truly

Yours,

Scientech Corporation Board of Directors

Audit Committee Convener: Cheng-Li Yang

February 2, 2025

8

III. 2024 Consolidated Financial Statements and Individual Financial Statements

Independent Auditors’ Report

SCIENTECH CORPORATION The Board of Directors and Shareholders:

Audit opinion

SCIENTECH CORPORATION and its subsidiaries (collectively referred to as the SCIENTECH Group) as of 31 December 2024 and 2023, and the Consolidated Balance Sheets, for the period from 1 January through 31 December 2024 and 2023, and the Consolidated Statements of Comprehensive Income, Consolidated Statements of Changes in Equity, Consolidated Statements of Cash Flows, and the Notes on Consolidated Financial Statements (including the summary of significant accounting policies), have been audited by our accountants.

In our opinion, the aforementioned Consolidated Financial Statements fairly present, in all material respects, the consolidated financial position of the SCIENTECH Group as of December 31, 2024 and 2023, and the consolidated financial performance and consolidated cash flows for the periods from January 1 to December 31, 2024 and 2023, in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and the International Financial Reporting Standards, International Accounting Standards, interpretations, and Statement on Internal Control (SIC) approved and promulgated by the Financial Supervisory Commission.

Basis of Audit Opinion

We conducted our audits in accordance with the Regulations Governing Financial Statement Audit and Attestation Engagements of Certified Public Accountants and the Standards on Auditing of the Republic of China. Our responsibilities under those standards are further described in the Auditors' Responsibilities for the Consolidated Financial Statements section of our report. The personnel of our affiliated firm subject to independence regulations have maintained independence from the SCIENTECH Group in accordance with the International Code of Ethics for Professional Accountants (IESBA Code), and fulfilled other responsibilities under that code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our o pinion.

9

Key Audit Matters

Key audit matters refer to matters that, in our professional judgment, were of most significance in the audit of the Consolidated Financial Statements of the SCIENTECH Group for the year 2024. These matters were addressed in the context of our audit of the consolidated financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these issues.

The Key Audit Matters for the SCIENTECH Group's 2024 Consolidated Financial Statements are stated as follows:

Revenue recognition

The SCIENTECH Group's operating revenue from agency and manufacturing machines for the year 2024 is significant to the overall financial statements. Machine revenue is recognized when performance obligations are fulfilled. Since the company might recognize sales revenue before meeting the conditions for recognizing souvenir (merchandise) revenue, it is listed as a key audit matter.

Our main audit procedures to address the said matter included testi ng the effectiveness of the design and implementation of the internal control system pertaining to the recognition of machinery sale and discussing with the management about whether the accounting policy for revenue recognition is appropriate and consistently adopted; we also sampled customer sales documents to verify the transaction terms on the order or sale contract and check the acceptance certificate signed off by customers, so as to assess the correctness of the recognized revenue.

Other Matters

SCIENTECH CORPORATION has prepared the Parent Company Only Financial Statement for the years 2024 and 2023, and our auditor has issued an audit report with unqualified opinions for reference.

Responsibilities of Management and Those Charged with Governan ce for the

Consolidated Financial Statements

The management was responsible for fairly presenting these consolidated financial statements in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and the International Financial Reporting Standards, International Accounting Standards, IFRIC interpretations, and SIC interpretations that were approved and promulgated by

10

the Financial Supervisory Commission, and for maintaining the necessary internal control related to the preparation of these consolidated financial statements to ensure that these consolidated financial statements were free of material misstatements, whether due to fraud or errors.

During preparation of these consolidated financial statements, the management was also responsible for evaluating The Group’s ability to continue as a going concern, disclosing going concern matters, and applying the going concern basis of accounting, unless the management intended either to liquidate The Group or to terminate its operations, or had no feasible alt ernatives but to do so.

The Group’s governance body (including the Audit Committee) was responsible for supervising the financial reporting procedures.

Auditors' Responsibilities for the Audit of the Consolidated Financial Statements

Our objectives in auditing the Consolidated Financial Statements are to obtain reasonable assurance about whether the Consolidated Financial Statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an audit report. Reasonable assurance is a high level of assurance, but an audit conducted in accordance with the Auditing Standards cannot guarantee that a material misstatement in the Consolidated Financial Statements will always be detected. Misstatements can arise from fraud or error. Misstatements are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated financial statements.

  • As part of an audit in accordance with the Standards on Auditing of the

  • Republic of China, we exercised professional judgment and maintained professional skepticism throughout the audit. We also conduct the following tasks: 1. Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

11

  1. Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Group ’s internal control.

  2. Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.

  3. Conclude on the appropriateness of management's use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Group's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the consolidated financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the Group to cease to continue as a going concern.

  4. Evaluate the overall presentation, structure and content of the consolidated financial statements, including the disclosures, and whether the consolidated financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

  5. Obtain sufficient and appropriate audit evidence regarding the financial information of the entities or business activities within the Group to express an opinion on the consolidated financial statements. We are responsible for directing, supervising, and executing the group's audit engagements and for forming the group's audit opinion.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

12

We determined the key audit matters for the audit of the SCIENTECH Group's 2024 Consolidated Financial Statements from the matters communicated with those charged with governance. We describe these matters in our auditor’s report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of do ing so would reasonably be expected to outweigh the public interest benefits of such communication.

Deloitte & Touche Taiwan CPA: HUI-MIN HUANG

CPA: YU-CHENG HSIN

Approval No. from the Financial Approval No. from the Financial Supervisory Commission Supervisory Commission Financial-Supervisory-SecuritiesFinancial-Supervisory-SecuritiesAuditing-Order No.1070323246 Auditing-Order No.1120349008

27 February 2025

13

SCIENTECH CORPORATION and Subsidiaries

Consolidated Balance Sheets

As of December 31, 2024 and 2023

Unit: NT$ thousand

C o d e

1100
1110
1170
1180
130X
1410
1470
11XX

1517
1550
1600
1755
1785
1840
1915
1975
1990
15XX
1XXX
C o d e

2100
2130
2170
2219
2230
2252
2280
2399
21XX

2530
2570
2580
25XX
2XXX

3110
3200
3310
3320
3350
3300
3410
3420
3400
3XXX
 A
s
s
e
t
s
Current Assets
Cash and cash equivalents (Notes 4 and 6)
Current financial assets at fair value through profit or loss(Notes 4
and 7)
Notes and accounts receivable (Notes 4, 9, and 21)
Accounts receivable - related parties (Notes 4, 9, 21, and 28)
Inventories (Notes 4, 10, and 25)
Prepayments
Other current assets (Notes 15, 28, and 29)
Total current assets
Non-current assets
Financial assets at fair value through other comprehensive income
(Notes 4 and 8)
Investments accounted for using equity method (Notes 4 and 12)
Property, plant and equipment (Notes 4, 13, and 25)
Right-of-use assets (Notes 4 and 14)
Patent right (Note 4)
Deferred tax assets (Notes 4 and 23)
Prepayments for equipment (Note 13)
Net defined benefit assets (Notes 4 and 19)
Other non-current assets (Note 15)
Total non-current assets
Total Assets
L i a b i l i t i e s a n d S t o c k h o l d e r s ’ E q u i t y
Current liabilities
Short-term borrowings (Note 16)
Contract liabilities (Notes 4, 21, and 28)
Notes payable and accounts payable
Other payables (Notes 13, 18, and 28)
Current tax liabilities (Notes 4 and 23)
Short-term warranty provision (Note 4)
Lease liabilities (Notes 4, 14, and 28)
Other current liabilities
Total current liabilities
Non-current liabilities
Bonds payable (Note 4 and 17)
Deferred tax liabilities (Notes 4 and 23)
Lease liabilities (Notes 4, 14, and 28)
Total non-current liabilities
Total liabilities
Equity (Notes 4, 12, and 20)
Capital stock
Capital surplus
Retained earnings
Legal reserves
Special reserve
Unappropriated earnings
Total retained earnings
Other equity
exchange differences on translation of foreign financial
statements
Unrealized valuation gains or losses on financial assets at fair
value through other comprehensive income
Total other equity interests
Total stockholders’ equity
Total Liabilities and Equity		 31 December 2024
A
m
o
u
n
t
％

$ 7,014,917
30
2,480
-
590,216
3
-
-
11,625,770
50
792,137
3
68,762

-
20,094,282

86
279,028
1
636,932
3
1,634,599
7
86,515
-
693
-
241,777
1
455,810
2
1,764
-
52,341

-
3,389,459

14
$ 23,483,741
100
$ 563,221
2
14,006,118
60
1,487,448
6
639,991
3
159,652
1
85,579
-
17,011
-
28,248

-
16,987,268

72
1,145,654
5
315,374
2
73,440

-
1,534,468

7
18,521,736

79
803,280

3
917,777

4
439,166
2
-
-
2,641,716

11
3,080,882

13
55,395
-
104,671

1
160,066

1
4,962,005

21
$ 23,483,741
100		 31 December 2023 31 December 2023
A
m
o
u
n
t
$ 7,014,917
2,480
590,216
-
11,625,770
792,137
68,762

20,094,282

279,028
636,932
1,634,599
86,515
693
241,777
455,810
1,764
52,341

3,389,459

$ 23,483,741

$ 563,221
14,006,118
1,487,448
639,991
159,652
85,579
17,011
28,248

16,987,268

1,145,654
315,374
73,440

1,534,468

18,521,736

803,280

917,777

439,166
-
2,641,716

3,080,882

55,395
104,671

160,066

4,962,005

$ 23,483,741
 A
m
o
u
n
t
$ 4,660,977
7,529
775,942
11,439
9,631,247
1,158,475
161,306

16,406,915

210,136
423,092
1,533,603
80,680
952
156,634
67,518
1,778
41,539

2,515,932

$ 18,922,847

$ 296,529
11,818,592
1,873,273
475,050
182,388
53,119
12,223
15,931

14,727,105

-
134,634
71,855

206,489

14,933,594

803,280

685,901

375,378
33,380
2,066,113

2,474,871

(
10,578 )
35,779

25,201

3,989,253

$ 18,922,847
 ％
25
-
4
-
51
6
1
87
1
2
8
1
-
1
-
-
-
13
100
2
62
10
3
1
-
-
-
78
-
1
-
1
79
4
4
2
-
11
13
-
-
-
21
100

The accompanying notes are an integral part of the consolidated financial statements.

Chairman of the Board: HUNG-LIANG HSIEH

Accounting Manager: SHAO-CHE CHUANG

Manager: MING-CHI HSU

14

SCIENTECH CORPORATION and Subsidiaries

Consolidated Statement of Comprehensive Income

January 1 to December 31, 2024 and 2023

Unit: NT$ thousand; except earnings per share

C o d e

Operating revenue (Notes 4,
21, and 28)
4100
Goods sales revenue

4600
Services revenue
4800
Other operating revenue
4000
Total operating
revenue
5000
operating costs (Notes 10 and
22)
5900
gross profit from operations
5910
Realized (unrealized) gains on
transactions with associates
(Note 4 and 12)
5950
Realized operating gross
profit
Operating expenses (Notes 9,
22, and 28)
6100
Marketing expenses
6200
General and
administrative
expenses
6300
R&D expenses

6000
Total operating
expenses
6900
Operating Income

(Continued)		 2024
％

97

3
-

100

70

30
-

30

13

2
4

19

11
 2023
A m o u n t
$ 9,400,488
277,278
10,514

9,688,280

6,787,607

2,900,673
5,154

2,905,827

1,197,462
215,263
377,553

1,790,278

1,115,549
 A m o u n t
$ 6,675,214

229,473
7,294

6,911,981

4,705,858


2,206,123
(
4,791 )

2,201,332


947,733

194,435
341,442

1,483,610

717,722
％
97

3
-
100
68
32
-
32
14

3
5
22
10

15

(Continued)

(Continued)
C o d e

Non-operating income and
expenses
7010
Other income (Note 4, 8,
and 28)
7020
Other gains and losses

7050
Finance costs (Notes 4,
22, and 28)
7060
Share of profit or loss of
associates accounted
for using equity
method (Notes 4 and
12)
7100
Income from
interests(Notes 4 )
7225
Gains on disposals of
investments(Notes 12)
7630
Exchange gains or losses
(Notes 4 and 31)
7670
Impairment loss (Notes 4
and 13)
7000
Total non-operating
income and
expenses
7900
Net profits before tax
7950
Tax expense (Notes 4 and 23)
8200
Net profit in the current year

Other comprehensive income
(Note 4)
Items that will not be
reclassified to profit or
loss
8311
Re-measurements of
defined benefit
plans (Note 19)		 2024
％


-

-

-

-

2

-

-
-

2

13
3

10


-		 2023
A m o u n t
$ 23,093
(
2,904 )
(
17,875 )
(
22,717 )
166,676
-
14,882
-

161,155

1,276,704
349,721

926,983

426		 A m o u n t
$ 37,993
(
6,424 )
(
4,587 )
(
30,649 )

121,266

80,634
(
54,695 )
(
916 )

142,622


860,344
210,042

650,302

(
217 )
％

-

-

-

-

2

1
(
1 )
-
2
12
3
9

-

(Continued)

16

(Continued)
C o d e

8316
Unrealized
valuation gains or
losses on
investment in
equity
instruments at fair
value through
other
comprehensive
income
8349
Income tax relating
to items that will
not be reclassified
subsequently to
profit or loss
(Note 23)
8310

Items that will be
reclassified to profit or
loss
8361
exchange
differences on
translation of
foreign financial
statements
8370
Share of other
comprehensive
income of
associates
accounted for
using the equity
method (Note 12)
8399
Income tax related
to items that
might be
reclassified (Note
23)
8360

(Continued)		 2024
％


1
-

1


-

-
-

-
 2023
A m o u n t
68,892
(
86 )

69,232

$ 66,196
16,270
(
16,493 )

65,973
 A m o u n t

71,574
43

71,400

( $ 7,630 )
(
8,759 )
3,283

(
13,106 )
％

1
-
1

-

-
-
-

17

(Continued)

(Continued)
C o d e

8300
Other
comprehensive
income (net after
tax)
8500
Total comprehensive income
for the year
Earnings per share (Note 24)
9710
Basic

9810
Diluted
 2024
％

1

11


 2023
A m o u n t
135,205

$ 1,062,188


$ 11.54
$ 11.36		 A m o u n t
58,294

$ 708,596

$ 8.10
$ 8.05
％
1
10

The accompanying notes are an integral part of the consolidated financial statements.

Chairman of the Board: Manager: Accounting Manager: HUNG-LIANG HSIEH MING-CHI HSU SHAO-CHE CHUANG

18

Unit: NT$ thousand

SCIENTECH CORPORATION and Subsidiaries Consolidated Statement of Changes in Equity January 1 to December 31, 2024 and 2023

C o d
e
A1
January 1, 2023 balance
M3 proceeds from disposal of investments
accounted for using equity method
2022 earning appropriation
B1
Legal reserves
B3
Special reserve
B5
Cash dividends
L3
Retirement of treasury share

D1
2023 net profit
D3
2023 other comprehensive income
(loss), net of income tax
Z1
31 December 2023 balance
2023 earning appropriation
B1
Legal reserves
B3
special reserve appropriated
B5
Cash dividends
C5
Issuance of convertible corporate bonds
recognized as part of the equity item
D1
Year 2024 net profit
D3
2024 year other comprehensive income
(loss), net of income tax
Z1
31 December 2024 balance
 C a p i t a l
s t o c k
A m o u n t
$ 811,390

-

-

-

-
(
8,110 )

-

-


803,280

-

-

-

-

-
-

$ 803,280
Capitalsurplus
$ 728,964
(
12,761 )

-

-

-
(
30,302 )

-

-


685,901

-

-

-

231,876

-
-

$ 917,777
 R
e
t
a
i
n
e
d
e
a
r
n
i
n
g
s
Special reserve
Unappropriated
e a r n i n g s
$ 14,306 $ 1,793,497

-
-

- (
57,010 )

19,074 (
19,074 )

- (
289,181 )

- (
12,247 )

-
650,302
-
(
174 )


33,380
2,066,113

- (
63,788 )
(
33,380 )
33,380

- (
321,312 )

-
-

-
926,983

-

340

$ -
$ 2,641,716
 O
t
h
e
r		 e
q
u
i
t
y
Through other
t
o
t
a
l
Profit or loss at
f a i r v a l u e
Val u at io n o f
Investment in
e
q
u
i
t
y
i n s t r u m e n t s
U n r e a l i z e d
valuation gains or
l
o
s
s
e
s
( $ 35,795 )

-

-

-

-

-

-
71,574


35,779

-

-

-

-

-
68,892

$ 104,671
 Treasury stock
( $ 50,659 )

-

-

-

-

50,659

-
-


-

-

-

-

-

-
-

$ -
 T
o
t
a
l
stockholders’
e
q
u
i
t
y
F o r e i g n
o p e r a t i o n s
Translation of
F i n a n c i a l
S t a t e m e n t s
E x c h a n g e
di f ferenc e s
$ 2,415

113

-

-

-

-

-
(
13,106 )

(
10,578 )

-

-

-

-

-
65,973

$ 55,395
Thousand shares
81,139
-
-
-
-
(
811 )
-
-

80,328
-
-
-
-
-
-

80,328
 Legal reserves
$ 318,368

-

57,010

-

-

-

-
-


375,378

63,788

-

-

-

-
-

$ 439,166
 Special reserve
$ 14,306

-

-

19,074

-

-

-
-


33,380

-
(
33,380 )

-

-

-

-

$ -
$ 3,582,486
(
12,648 )

-

-
(
289,181 )

-

650,302
58,294

3,989,253

-

-
(
321,312 )

231,876

926,983
135,205
$ 4,962,005

The accompanying notes are an integral part of the consolidated financial statements.

Chairman of the Board: HUNG-LIANG HSIEH

Manager: MING-CHI HSU Accounting Manager: SHAO-CHE CHUANG

19

SCIENTECH CORPORATION and Subsidiaries Consolidated Statement of Cash Flows January 1 to December 31, 2024 and 2023

A. Unit: NT$ thousand

C o d e
Cash flow from operating activities
A10000
Net profits before tax

A20010
reconcile profit item
A20100
Depreciation
A20200
Amortization expense
A20300
Expected credit reversal of
impairment loss recognized in
profit or loss

A20900
Financial cost
A21200
Income from interests

A21300
Dividend Income

A20400
Net loss (gain) of financial assets at
fair value through profit or loss

A22300
Share of profit or loss of associates
accounted for using equity
method
A22500
(Gain) loss on disposal and
retirement of property, plant, and
equipment

A23100
Gain on disposal of investments
A23700
Impairment loss on non-financial
assets
A23900
(Realized) Unrealized gains on
transactions with associates

A24100
Unrealized foreign exchange loss
(gain)
A29900
Defined benefit cost
A30000
Net changes in operating assets and
liabilities
A31150
notes and accounts receivable
A31160
Accounts receivable - related
parties
A31200
Inventories

A31230
Prepayments
A31240
other current assets
A32125
Contract liabilities

A32150
Notes payable and accounts
payable

A32180
Other payables
(Continued)		 2024
$ 1,276,704

135,480
259
(
4,781 )
17,875
(
166,676 )
(
4,045 )
(
2,794 )
22,717
(
4 )
-

353,180
(
5,154 )
35,865

599

208,155
12,443

( 2,288,733 )
380,048
98,046
2,053,672

(
442,092 )
135,132		 2023
$ 860,344
121,304
260
(
3,806 )
4,587
(
121,266 )
(
3,998 )

248
30,649

12
(
80,634 )
339,097

4,791
(
48,743 )
(
22 )
75,669
(
7,071 )
( 4,774,819 )
642,190
25,688
4,153,305
(
228,335 )
76,023

20

(Continued)
C o d e
A32200
short-term warranty provision
A32230
Other current liabilities
A32240
Net defined benefit liabilities

A33000
Cash flow from operating activities

A33100
Interest received
A33300
Interest paid

A33500
Income taxes paid

AAAA
Net cash flows from (used in) operating
activities

Cash Flow from Investing Activities
B00200
Proceeds from disposal of financial
assets at fair value through profit or
loss
B01800
Acquisition of long-term equity
investments accounted for using the
equity method

B01900
Disposal of long-term equity
investments accounted for using the
equity method.
B02700
Acquisition of property, plant and
equipment

B02800
Proceeds from disposal or property,
plant and equipment
B06700
Increase in other non-current assets

B07600
Dividends received

BBBB
Net cash flows from (used in) investing
activities

Cash Flow from Financing Activities
C00100
Increase in short-term borrowings
C00200
Decrease in short-term borrowings

C01200
proceeds from issuing bonds

C04020
Repayment of principal of lease
liabilities

C04500
Cash dividends paid

CCCC
Net cash flows from financing activities
(used in)

DDDD
Effects of exchange rate changes on cash
and cash equivalents

EEEE
Increase in cash and cash equivalents

(Continued)
(Continued)
C o d e
E00100 Cash and cash equivalents - beginning of year		 2024
31,436
12,317

(
159 )

1,859,490

166,676
( $ 5,122 )
(
295,413 )

1,725,631

7,385
(
215,133 )
-
(
546,820 )
125
(
10,703 )
4,045

(
761,101 )

657,608
(
401,761 )
1,365,243
(
17,593 )
(
321,312 )

1,282,185

107,225

2,353,940
2024
4,660,977
 2023
12,290
(
1,185 )
(
131 )
1,076,447
121,266
( $ 4,641 )
(
188,951 )
1,004,121
38,716

-
48,940
(
59,221 )
3
(
6,825 )
3,998
25,611
326,685
(
455,080 )
-
(
10,203 )
(
289,181 )
(
427,779 )
(
22,927 )
579,026
2023
4,081,951

21

$ 7,014,917

$ 4,660,977

E00200 Cash and cash equivalents - end of year

The accompanying notes are an integral part of the consolidated financial statements.

Chairman of the Board: Manager: Accounting Manager: HUNG-LIANG HSIEH MING-CHI HSU SHAO-CHE CHUANG

22

Independent Auditors’ Report

SCIENTECH CORPORATION The Board of Directors and Shareholders:

Audit opinion

SCIENTECH CORPORATION's Parent Company Only Balance Sheets as of December 31, 2024 and 2023, and the Parent Company Only Statements of Comprehensive Income, Parent Company Only Statements of Changes in Equity, Parent Company Only Statements of Cash Flows for the period from January 1 through December 31, 2024 and 2023, and the notes to the parent company only financial statements (including the summary of significant accounting policies), have been audited by our accountants.

In our opinion, the aforementioned parent company only financial statements are prepared, in all material respects, in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers, and they fairly present the financial position of SCIENTECH CORPORATION as of 31 December 2024 and 2023, and its financial performance and cash flows for the periods from 1 January to 31 December 2024 and 2023.

Basis of Audit Opinion

We conducted our audits in accordance with the Regulations Governing Financial Statement Audit and Attestation Engagements of Certified Public Accountants and the Standards on Auditing of the Republic of China. Our responsibilities under those standards are further described in the Auditors' Responsibilities for the Parent Company Only Financial Statements section of our report. The personnel of our affiliated firm have adhered to the International Code of Ethics for Professional Accountants (IESBA Code), maintaining impartial independence with SCIENTECH CORPORATION and fulfilling other responsibilities under the code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Key Audit Matters

Key Audit Matters refer to matters that, in our professional judgment, were of most significance in the audit of the SCIENTECH CORPORATION parent company only financial statements for the year 2024. These matters were

23

addressed in the context of our audit of the parent company only financial statements as a whole and in forming our opinion thereon, and we do not provide a separate opinion on these issues.

The key audit matters of the individual financial statements of SCIENTECH CORPORATION for the year 2024 are stated as follows: Revenue recognition

SCIENTECH CORPORATION in the year 2024, due to the operating revenue from agency and manufacturing of machines being significant to the overall financial statements, recognizes machine revenue upon fulfillment of performance obligations. Since the Company may recognize sales revenue without meeting the recognition criteria for souvenir (merchandise) revenue, it is classified as a key audit matter.

Our main audit procedures to address the said matter included testing the effectiveness of the design and implementation of the internal control system pertaining to the recognition of machinery sale and discus sing with the management about whether the accounting policy for revenue recognition is appropriate and consistently adopted; we also sampled customer sales documents to verify the transaction terms on the order or sale contract and check the acceptance certificate signed off by customers, so as to assess the correctness of the recognized revenue.

Responsibilities of Management and Those Charged with Governance for the Parent Company Only Financial Statements

Management is responsible for the preparation and fair presentation of the parent company only financial statements in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers, and for such internal control as management determines it is necessary to enab le the preparation of parent company only financial statements that are free from material misstatements, whether due to fraud or error.

In preparing the parent company only financial statements, management is responsible for assessing the SCIENTECH CORPORATION's ability to continue as a going concern, disclosing, as applicable, matters related to going concern, and using the going concern basis of accounting unless management either intends to liquidate the SCIENTECH CORPORATION or to cease operations or has no realistic alternative but to do so.

24

Those charged with governance, including the audit committee, are responsible for overseeing SCIENTECH CORPORATION's financial reporting process.

Auditors' Responsibilities for the Parent Company Only Financial Statements

Our objectives are to obtain reasonable assurance about whether the parent company only financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors' report that include s our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with the Standards on Auditing of the Republic of China will always detect a material misstatement when it exists in these parent company only financial statements. Misstatements can arise from fraud or error. Misstatements are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these individual financial statements.

As part of an audit in accordance with the Standards on Auditing of the Republic of China, we exercised professional judgment and maintained professional skepticism throughout the audit. We also conduct the following tasks:

  1. Identify and assess the risks of material misstatement of the parent company only financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

  2. Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances but not for the purpose of expressing an opinion on the effectiveness of the SCIENTECH CORPORATION’s internal control.

  3. Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.

  4. Conclude on the appropriateness of management's use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the SCIENTECH CORPORATION’s ability to continue

25

as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the parent company only financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the SCIENTECH CORPORATION to cease to continue as a going concern.

  1. Evaluate the overall presentation, structure and content of the parent company only financial statements, including the disclosures and whether or not the financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

  2. Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within SCIENTECH CORPORATION to express an opinion on the parent company only financial statements. The auditor is responsible for directing, supervising, and executing the audit engagement and for forming the audit opinion of SCIENTECH CORPORATION.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and signific ant audit findings, including any significant deficiencies in internal control that we identify during our audit.

26

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards. We determined the key audit matters for the audit of the 2024 individual financial statements of SCIENTECH CORPORATION from the matters communicated with those charged with governance. We describe these matters in our auditor’s report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

Deloitte & Touche Taiwan CPA: HUI-MIN HUANG

CPA: YU-CHENG HSIN

Approval No. from the Financial Supervisory Commission

Financial-Supervisory-SecuritiesAuditing-Order No.1070323246

Approval No. from the Financial Supervisory Commission Financial-Supervisory-SecuritiesAuditing-Order No.1120349008

February 27, 2025

27

SCIENTECH CORPORATION

Parent Company Only Balance Sheet

As of December 31, 2024 and 2023

Unit: NT$ thousand

C o d e

1100
1110
1170
1180
130X
1410
1470
11XX

1517
1550
1600
1755
1785
1840
1915
1975
1990
15XX
1XXX

C o d e

2100
2130
2170
2219
2230
2252
2280
2399
21XX

2530
2570
2580
2620
25XX
2XXX

3110
3200
3310
3320
3350
3300
3410
3420
3400
3XXX
 A
s
s
e
t
s
Current Assets
Cash and cash equivalents (Notes 4 and 6)
Current financial assets at fair value through profit or loss(Notes 4
and 7)
Notes receivable and accounts receivable (Notes 4, 9, and 20)
Accounts receivable - related parties (Notes 4, 9, 20, and 27)
Inventories (Notes 4, 10, 24, and 27)
Prepayments
Other current assets (Notes 14, 27, and 28)
Total current assets
Non-current assets
Financial assets at fair value through other comprehensive income
(Notes 4 and 8)
Investments accounted for using equity method (Notes 4 and 11)
Property, plant and equipment (Notes 4, 12, and 24)
Right-of-use assets (Notes 4 and 13)
Patent right (Note 4)
Deferred income tax assets (Notes 4 and 22)
Prepayments for equipment (Note 12)
Net defined benefit assets (Notes 4 and 18)
Other non-current assets (Note 14)
Total non-current assets
Total Assets
L i a b i l i t i e s a n d S t o c k h o l d e r s ’ E q u i t y
Current liabilities
Short-term borrowings (Note 15)
Contract liability (Notes 4, 20 , and 27)
Notes payable and accounts payable (Note 27)
Other payables (Notes 12, 17, and 27)
Current income tax liabilities (Notes 4 and 22)
Short-term warranty provision (Note 4)
Lease liabilities (Notes 4, 13, and 27)
Other current liabilities
Total current liabilities
Non-current liabilities
Bonds payable (Notes 4 and 16)
Deferred income tax liabilities (Notes 4 and 22)
Lease liabilities (Notes 4, 13, and 27)
Long-term accounts payable to related parties (Notes 27)
Total non-current liabilities
Total liabilities
Equity (Notes 4 and 19)
Capital stock
Capital surplus
Retained earnings
Legal reserves
Special reserve
Unappropriated earnings
Total retained earnings
Other equity
exchange differences on translation of foreign financial
statements
Unrealized valuation gains or losses on financial assets at fair
value through other comprehensive income
Total other equity interests
Total stockholders’ equity
Total Liabilities and Equity		 31 December 2024
A
m
o
u
n
t
％

$ 4,544,695
23
2,480
-
510,990
3
5,312
-
9,246,466
46
666,527
3
18,046

-
14,994,516
75
279,028
2
2,350,648
12
1,593,816
8
77,314
-
1,698
-
241,405
1
455,810
2
1,764
-
50,265

-
5,051,748
25
$ 20,046,264
100
$ 563,221
3
10,832,711
54
1,206,423
6
642,326
3
92,387
1
56,330
-
14,363
-
28,231

-
13,435,992
67
1,145,654
6
315,374
1
66,333
-
120,906

1
1,648,267

8
15,084,259
75
803,280

4
917,777

5
439,166
2
-
-
2,641,716
13
3,080,882
15
55,395
-
104,671

1
160,066

1
4,962,005
25
$ 20,046,264
100		 31 December 2023 31 December 2023
A
m
o
u
n
t
$ 4,544,695

2,480
510,990
5,312
9,246,466

666,527
18,046

14,994,516

279,028
2,350,648

1,593,816
77,314
1,698
241,405
455,810
1,764
50,265

5,051,748

$ 20,046,264

$ 563,221
10,832,711

1,206,423
642,326
92,387
56,330
14,363
28,231

13,435,992

1,145,654
315,374
66,333
120,906

1,648,267

15,084,259

803,280

917,777

439,166
-
2,641,716

3,080,882

55,395
104,671

160,066

4,962,005

$ 20,046,264
 A
m
o
u
n
t
$ 2,948,723

7,529
534,241
11,797
7,319,127

730,499
13,631

11,565,547

210,136
1,278,290
1,489,494

69,012
2,036
156,534
67,518
1,778
39,553

3,314,351

$ 14,879,898

$ 296,529
8,243,994

1,346,615
466,934
126,254
32,110
9,169
15,916

10,537,521

-
134,634
62,718
155,772

353,124

10,890,645

803,280

685,901

375,378
33,380
2,066,113

2,474,871

(
10,578 )
35,779

25,201

3,989,253

$ 14,879,898
 ％
20
-
4
-
49
5
-
78
1
9
10
1
-
1
-
-
-
22
100
2
56
9
3
1
-
-
-
71
-
1
-
1
2
73
5
5
3
-
14
17
-
-
-
27
100

The accompanying notes are an integral part of the parent company only financial statements.

Chairman of the Board: HUNG-LIANG HSIEH Manager: MING-CHI HSU

Accounting Manager: SHAO-CHE CHUANG

28

SCIENTECH CORPORATION

Parent Company Only Statement of Comprehensive Income

January 1 to December 31, 2022 and 2021

Unit: NT$ thousand; except earnings per share

C o d e

Operating revenue (Notes 4,
20, and 27)
4100
Goods sales revenue

4600
Services revenue
4800
Other operating revenue

4000
Total operating
revenue

5000
Operating costs (Notes 10, 21,
and 27)

5900
gross profit from operations

5910
Realized (unrealized) gains on
transactions with associates
(Notes 4 and 11)

5950
Realized operating gross profit
Operating expenses (Notes 4,
9, 21, and 27)
6100
Marketing expenses
6200
General and
administrative expenses
6300
R&D expenses

6000
Total operating
expenses

6900
Operating Income

Non-operating income and
expenses
7010
Other income (Notes 4, 8,
and 27)
7020
Other gains and losses
(Note 4)
(Continued)		 2024
％

97


3
-

100

72

28

-

28

14

3
6

23

5


-

-
 2023
A m o u n t
$ 5,609,341
173,936
10,430

5,793,707
4,204,993

1,588,714
5,154

1,593,868

810,002

154,391
376,687

1,341,080

252,788

14,216
1,556		 A m o u n t
$ 3,800,173

138,898
9,151

3,948,222

2,596,663

1,351,559

(
4,791 )

1,346,768

532,868

136,554
340,589

1,010,011

336,757

34,758
(
2,542 )
％
96
4
-
100
66
34
-
34
14
3
9
26
8
1

-

29

(Continued)

(Continued)
C o d e

7030
Gains on disposals of
investments(Notes 11)

7050
Financial cost (Notes 4, 21,
and 27)

7070
Share of profit or loss of
associates and subsidiaries
accounted for using equity
method (Notes 4 and 11)
7100
Interest revenue (Notes 4 and
27)
7630
Exchange gains or losses
(Notes 4 and 30)
7670
Impairment loss (Notes 4 and
12)

7000
Total non-operating
income and expenses
7900
Net profits before tax

7950
Income tax expenses (Notes 4 and
22)

8200
Net profit in the current year

Other comprehensive income
(Note 4)
Items that will not be
reclassified to profit or loss
8311
Re-measurements of
defined benefit plans
(Note 18)
8316
Unrealized valuation
gains or losses on
investment in equity
instruments at fair
value through other
comprehensive
income
8349
Income tax related to
items that will not be
reclassified (Note 22)
8310

(Continued)		 2024
％


-

-
13

1

1
-

15

20
4

16


-

1
-

1
 2023
A m o u n t
$ -
(
20,347 )
772,773
84,121
26,286
-

878,605

1,131,393
204,410

926,983


426
68,892
(
86 )

69,232
 A m o u n t
$ 80,634

(
4,529 )

268,068


64,062

(
7,617 )
(
916 )

431,918


768,675

118,373

650,302

(
217 )

71,574

43

71,400
％
2

-
7
1

-
-
11
19
3
16

-
2
-
2

30

(Continued)
C o d e

Items that will be
reclassified to profit or
loss
8380
Share of other
comprehensive
income of
associates and
subsidiaries
accounted for
using equity
method (Note 11)
8399
Income tax related
to items that
might be
reclassified (Note
22)

8360

8300
Other
comprehensive
income (net after
tax)

8500
Total comprehensive income
for the year

Earnings per share (Note 23)
9710
Basic

9810
Diluted
 2024
％

1

-

1

2

18


 2023
A m o u n t
$ 82,466
(
16,493 )

65,973

135,205

$ 1,062,188


$ 11.54
$ 11.36		 A m o u n t
( $ 16,389 )
3,283

(
13,106 )

58,294

$ 708,596

$ 8.10
$ 8.05
％

-
-
-
2
18

The accompanying notes are an integral part of the parent company only financial statements.

Chairman of the Board: Manager: Accounting Manager: HUNG-LIANG HSIEH MING-CHI HSU SHAO-CHE CHUANG

31

SCIENTECH CORPORATION

Parent Company Only Statement of Changes in Equity January 1 to December 31, 2024 and 2023


Code

A1
January 1, 2023 balance
M3
proceeds from disposal of investments
accounted for using equity method
Earning appropriation for 2022
B1
Legal reserves
B3
special reserve appropriated
B5
Cash dividends
L3
Retirement of treasury share

D1
2023 net profit
D3
2023 other comprehensive income
(loss), net of income tax

Z1
31 December 2023 balance
2023 earning appropriation
B1
Legal reserves
B3
Special reserve
B5
Cash dividends
C5
Issuance of convertible corporate
bonds recognized as part of equity
item
D1
2024 net profit
D3
2024 other comprehensive income
(loss), net of income tax

Z1
31 December 2024 balance
 C a p i t a l
s t o c k
A m o u n t
$ 811,390

-

-

-

-
(
8,110 )

-

-


803,280

-

-

-

-

-
-

$ 803,280
Capitalsurplus
$ 728,964
(
12,761 )

-

-

-
(
30,302 )

-

-


685,901

-

-

-

231,876

-
-

$ 917,777
 R
e
t
a
i
n
e
d
e
a
r
n
i
n
g
s
Special reserve
Unappropriated
e a r n i n g s
$ 14,306 $ 1,793,497

-
-

- (
57,010 )

19,074 (
19,074 )

- (
289,181 )

- (
12,247 )

-
650,302
-
(
174 )


33,380
2,066,113

- (
63,788 )
(
33,380 )
33,380

- (
321,312 )

-
-

-
926,983
-

340

$ -
$ 2,641,716
 O
t
h
e
r		 e
q
u
i
t
y






Through other
t
o
t
a
l
Profit or loss at
f a i r v a l u e
Va l u a t i o n o f
E
q
u
i
t
y
i n s t r u m e n t s
U n r e a l i z e d
i n v e s t m e n t
Valuation gains or
l
o
s
s
e
s

( $ 35,795 )

-

-

-

-

-

-

71,574


35,779

-

-

-

-

-

68,892

$ 104,671
 Treasury stock
( $ 50,659 )

-

-

-

-

50,659

-
-


-

-

-

-

-

-
-

$ -
 T
o
t
a
l
stockholders’
e
q
u
i
t
y
F o r e i g n
o p e r a t i o n s
Translation of
F i n a n c i a l
S t a t e m e n t s
E x c h a n g e
di f ferenc e s
Thousand shares
81,139
-
-
-
-
(
811 )
-
-

80,328
-
-
-
-
-
-

80,328
 Legal reserves
$ 318,368

-

57,010

-

-

-

-

-


375,378

63,788

-

-

-

-
-

$ 439,166
 Special reserve
$ 14,306

-

-

19,074

-

-

-
-


33,380

-
(
33,380 )

-

-

-
-

$ -
$ 2,415

113

-

-

-

-

-
(
13,106 )
(
10,578 )

-

-

-

-

-
65,973
$ 55,395














$ 3,582,486
(
12,648 )

-

-
(
289,181 )

-

650,302
58,294

3,989,253

-

-
(
321,312 )

231,876

926,983
135,205
$ 4,962,005

The accompanying notes are an integral part of the parent company only financial statements.

Chairman of the Board: HUNG-LIANG HSIEH

Manager: MING-CHI HSU

Accounting Manager: SHAO-CHE CHUANG

32

SCIENTECH CORPORATION

Parent Company Only Statement of Cash Flows

January 1 to December 31, 2024 and 2023

Unit: NT$ thousand

C o d e
Cash flow from operating activities
A10000
Net profits before tax

A20010
reconcile profit item
A20100
Depreciation
A20200
Amortization expense
A20300
Expected
credit
reversal
of
impairment loss recognized in
profit or loss

A20900
Financial cost
A21200
Income from interests

A21300
Dividend Income

A20400
Net loss (gain) of financial assets
measured at fair value through
profit or loss

A22300
Share of profit or loss of
associates
and
subsidiaries
accounted for using equity
method

A22500
loss on disposal of property, plant
and equipment
A23100
Gain on disposal of investments
A23700
Impairment loss on non-financial
assets
A23900
Unrealized
(Realized)
losses
(gains) on transactions with
associates

A24100
Unrealized foreign exchange loss
(Gain)
A29900
Defined benefit cost
A30000
Net changes in operating assets and
liabilities
A31150
notes and accounts receivable
A31160
Accounts receivable - related
parties
A31200
Inventories

A31230
Prepayments
A31240
other current assets

A32125
Contract liabilities

(Continued)		 2024
$ 1,131,393

127,347
338
(
7,559 )

20,347
(
84,121 )

(
4,045 )

(
2,794 )
(
772,773 )

8

-

436,917
(
5,154 )
35,383

599

39,481
7,554

( 2,395,136 )

63,972
(
3,457 )

2,588,717
 2023
$ 768,675
113,237
338
(
7,449 )
4,529
(
64,062 )
(
3,998 )
248
(
268,068 )
-
(
80,634 )
202,135
4,791
(
53,306 )
(
22 )
120,639
(
7,429 )
( 3,855,221 )
749,889
(
2,287 )
3,774,702

33

(Continued)
C o d e
A32150
Notes payable and accounts
payable

A32180
Other payables
A32200
short-term warranty provision
A32230
Other current liabilities
A32240
Net defined benefit liabilities
(assets)

A33000
Cash flow from operating activities

A33100
Interest received

A33300
Interest paid

A33500
Income taxes paid

AAAA
Net cash flows from (used in)
operating activities

Cash Flow from Investing Activities
B00200
Proceeds from disposal of financial
assets at fair value through profit or
loss
B01800
Acquisition
of
long-term
equity
investments accounted for using the
equity method

B01900
Disposal
of
long-term
equity
investments accounted for using the
equity method.
B02700
Acquisition of property, plant and
equipment

B06700
Increase in other non-current assets

B07600
Dividends received

BBBB
Net cash flows from (used in)
investing activities

Cash Flow from Financing Activities
C00100
Increase in short-term borrowings
C00200
Decrease in short-term borrowings

C01200
proceeds from issuing bonds

C03700
increase in other payable to related
parties (decrease)

C04020
Repayment of principal of lease
liabilities

C04500
Cash dividends paid

CCCC
Net cash flows from financing
activities (used in)

(Continued)		 2024
(
168,896 )

145,318
24,220

12,315

(
159 )

1,189,815

$ 84,121

(
7,594 )

(
158,987 )

1,107,355

7,385
(
215,133 )

3,167
(
546,555 )

(
10,712 )

4,045

(
757,803 )

657,608
(
401,761 )

1,365,243
(
38,943 )
(
14,415 )

(
321,312 )

1,246,420
 2023
(
391,479 )
29,983
(
450 )
(
1,189 )
(
131 )
1,033,441
$ 64,062
(
4,583 )
(
133,328 )
959,592
38,716
(
9,970 )
48,940
(
56,659 )
(
7,225 )
3,998
17,800
326,684
(
449,363 )
-
198,207
(
7,618 )
(
289,181 )
(
221,271 )

34

(Continued)
C o d e
EEEE
Increase in cash and cash equivalents

E00100 Cash and cash equivalents - beginning of
year

E00200 Cash and cash equivalents - end of year
 2024
1,595,972
2,948,723

$ 4,544,695
 2023
756,121
2,192,602
$ 2,948,723

The accompanying notes are an integral part of the parent company only financial statements.

Chairman of the Board: Manager: Accounting Manager:
HUNG-LIANG HSIEH MING-CHI HSU SHAO-CHE CHUANG

35

IV. Comparison Table for the Articles of Incorporation before and after amendment

Article After amendment Before amendment Remarks
20 If the Company has earnings at the
end of year, it shall allocate
5%~15% of such earnings as
employee remuneration;Of the
amount of employee remuneration,
no less than 15% should be
allocated to remuneration for
grassroots employees. the Board of
Directors shall allocate no more
than 2% of such earnings as
director remuneration. The
employee remuneration proposal
and director remuneration proposal
shall be submitted and reported to
the shareholders' meeting.
(Below Omitted)		 If the Company has earnings at the
end of year, it shall allocate
5%~15% of such earnings as
employee remuneration; the Board
of Directors shall allocate no more
than 2% of such earnings as
director remuneration. The
employee remuneration proposal
and director remuneration proposal
shall be submitted and reported to
the shareholders' meeting.
(Below Omitted)		 In accordance
with the
operational
needs and
Article 14,
Paragraph 6
of the
Securities and
Exchange
Act, the
Company's
Articles of
Incorporation
is hereby
amended.
22 Article 22 is additionally listed as
“The 36th revision was made on
May 23, 2025.”		 (Omitted) To align with
the amended
provisions,
the revision
date is added

36

More from Scientech

AGM Information 2026
Jun 11
Capital/Financing Update 2026
Jun 11
Capital/Financing Update 2026
Jun 11
AGM Information 2026
Jun 11
Regulatory Filings 2026
Jun 9
Regulatory Filings 2026
Jun 9
Declaration of Voting Results & Voting Rights Announcements 2026
Jun 5
Share Issue/Capital Change 2026
Jun 4
Regulatory Filings 2026
Jun 3
Regulatory Filings 2026
May 18
View all filings →